Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Talazoparib Plus Enzalutamide in Patients With HRR-Deficient mCRPC: Practical Implementation Steps for Oncology Nurses and Advanced Practice Providers.
Journal: Clinical journal of oncology nursing
Published: September 26, 2024
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 14, 2020
The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells.
Journal: Prostate cancer and prostatic diseases
Published: March 27, 2020
Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: January 30, 2020
Salvage-targeted kidney cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experience.
Journal: Cancer journal (Sudbury, Mass.)
Published: May 28, 2013
Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma.
Journal: European urology
Published: November 21, 2011
Showing 1-7 of 7
Last Updated: 09/26/2026